Edition:
United States

Genmab A/S (GEN.CO)

GEN.CO on Copenhagen Stock Exchange

1,199.50DKK
10:59am EDT
Change (% chg)

kr.-3.50 (-0.29%)
Prev Close
kr.1,203.00
Open
kr.1,192.50
Day's High
kr.1,217.00
Day's Low
kr.1,187.00
Volume
168,841
Avg. Vol
169,558
52-wk High
kr.1,239.00
52-wk Low
kr.786.20

About

Genmab A/S is a Denmark-based biotechnology company. It is engaged in the development of differentiated human antibody therapeutics for the treatment of cancer, as well as other medical conditions, such as relapsing remitting multiple sclerosis. Its product pipeline includes a number of research and development projects in... (more)

Overall

Beta: 1.22
Market Cap(Mil.): kr.74,201.72
Shares Outstanding(Mil.): 61.68
Dividend: --
Yield (%): --

Financials

  GEN.CO Industry Sector
P/E (TTM): 56.80 95.23 35.62
EPS (TTM): 21.18 -- --
ROI: 18.16 7.52 11.69
ROE: 18.38 8.09 16.40

Earnings vs. Estimates